Democrat New Mexico state representatives and senators joined other Democrat pro-abortion legislators from across the country in asking the U.S. Supreme Court to overturn an appellate court decision restricting access to mifepristone—the first of two drugs used for abortions. This move is in response to the ongoing legal challenge led by the Alliance for Hippocratic Medicine, aiming to roll back expanded access to the dangerous medication.
The amicus brief was organized by the State Innovation Exchange’s Reproductive Freedom Leadership Council, emphasizing the legislators’ commitment to protecting and supporting abortion.
While proponents argue that mifepristone ensures safe and accessible abortions, critics, including the Alliance for Hippocratic Medicine, claim that the drug poses serious safety risks. The Alliance Defending Freedom, representing the plaintiffs, contends that the FDA unlawfully approved mifepristone in 2000 and alleges its association with numerous deaths—an assertion contradicted by credible sources.
The legal battle surrounding mifepristone intensified after the U.S. Supreme Court’s Dobbs decision in June 2022, which called for abortion regulations to be determined by individual states. Legislators supporting the amicus brief argue that this decision reinforces the need for state autonomy on abortion-related issues.
Two lawmakers, Senator Erin Maye Quade from Minnesota and Representative Julie von Haefen from North Carolina, are leading the effort. They claim the Court must uphold FDA authority over medication approval and ensure access to the dangerous drug.
Seven New Mexico legislators joined the amicus brief, including the following:
- Rep. Pamelya Herndon (D-Albuquerque)
- Rep. Dayan Hochman-Vigil (D-Albuquerque)
- Rep. Micaela Lara Cadena (D-Las Cruces)
- Rep. Charlotte Little (D-Albuquerque)
- Rep. Andrea Romero (D-Santa Fe)
- Sen. Mimi Stewart (D-Albuquerque)
- Sen. Daniel A. Ivey-Soto (D-Albuquerque)
The Supreme Court has yet to decide whether it will hear the case.